AI Monitoring for Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
The trial aims to find a cost-effective way to monitor heart health in cancer survivors using AI technology. It focuses on individuals who have survived lymphoma or sarcoma and are either starting or have completed anthracycline therapy, a common cancer treatment. Participants will use a smartwatch (called WATCH) to track heart function and fitness levels, helping to detect early signs of heart problems. This trial suits those who have completed or are starting anthracycline treatment and can follow the study's procedures. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance heart health monitoring for future cancer survivors.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this AI monitoring method is safe for cancer survivors?
Research has shown that wearable devices, such as smartwatches, are generally safe for tracking health information. One study demonstrated that smartwatches effectively monitored patients with brain cancer without causing harm. Another study found that these devices can detect health changes in cancer patients, enabling doctors to identify problems early.
Researchers have also discovered that smartwatches can track vital signs in cancer patients, helping to catch issues before they become serious. Overall, using a smartwatch to monitor health in cancer survivors, as the research suggests, typically does not lead to any side effects or risks.12345Why are researchers excited about this trial?
Researchers are excited about the AI Monitoring for Cancer Survivors trial because it introduces a novel approach to monitoring heart health in lymphoma and sarcoma survivors. Unlike traditional follow-up care that might rely on periodic in-person check-ups, this trial uses an Apple Watch to continuously track ECG and cardio fitness data. This real-time monitoring allows for more immediate detection of heart issues, which is crucial for patients who have undergone anthracycline-based therapy, known to affect the heart. By employing technology for continuous data collection, this method aims to enhance patient outcomes and potentially prevent long-term cardiac complications.
What evidence suggests that this AI monitoring method is effective for cardiovascular surveillance in cancer survivors?
Research shows that wearable devices like the Apple Watch can help monitor the health of cancer survivors. In this trial, participants in the Longitudinal Arm can record ECG and cardio fitness data through an Apple Watch from before up to one year after anthracycline treatment. Studies have found that these smartwatches accurately track heart health and physical activity, which is crucial for those who have undergone cancer treatments. For example, researchers at the Cleveland Clinic discovered that data from smartwatches can help predict disease progression and identify complications. Additionally, using wearable activity trackers has been linked to better health outcomes, such as timely medication adherence and symptom tracking. This suggests that a smartwatch could effectively monitor heart health after cancer treatment.24678
Who Is on the Research Team?
Joerg Herrmann, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
The WATCH trial is for cancer survivors, specifically those who have had sarcoma or lymphoma. Participants should be interested in long-term heart health monitoring using wearable technology like an Apple Watch and willing to undergo various tests such as ECGs, echocardiograms, and exercise assessments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are monitored using AI-ECG and Apple Watch for cardiac function during and after anthracycline-based therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- WATCH
Trial Overview
This study is testing the effectiveness of AI-powered mobile devices and smartwatches in detecting heart problems in cancer survivors. It involves regular cardiovascular monitoring through non-invasive methods like wearables to prevent heart failure risks.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Lymphoma and sarcoma cancer survivors will be seen before the start of anthracycline-based therapy and followed every three months up to 1 year after completion of therapy. Longitudinal participants will have the option of recording ECG and cardio fitness data through an Apple Watch from before up to 1 year post anthracycline treatment.
Lymphoma and sarcoma cancer survivors will be seen at one time point, 1 year after completion of anthracycline-based therapy.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Citations
Meta-Analysis of Randomized Controlled Trials - PMC
Researchers from 21 studies assessed the effectiveness of WEDS-supported PA programs on the QoL of cancer survivors. The random-effects model ...
Associations of Wearable Activity Tracker Use With ...
This study aims to determine the association of wearable activity trackers with physical activity and health outcomes in patients with cancer.
Consumer Wearables and the Integration of New Objective ...
Wearable research in oncology applications has demonstrated benefits, such as improved medication adherence and accuracy of symptom tracking, over self-reported ...
4.
consultqd.clevelandclinic.org
consultqd.clevelandclinic.org/can-smartwatch-data-predict-progression-and-detect-complications-in-patients-with-glioblastomaCan Smartwatch Data Help Monitor Patients With Glioblastoma?
Cleveland Clinic researchers are harnessing the power of smartwatch data to predict disease progression in patients with glioblastoma.
Evaluating Digital Biomarkers from Apple Watch Data to ...
Explore how Apple Watch-derived digital biomarkers can transform cancer care by providing real-world insights into patient health.
Experiences with Wearable Sensors in Oncology during ...
The aim of this case report is to describe the Danish research experience with wearable sensors in oncology reporting from three oncological wearable research ...
Wearable device use and technology preferences in ...
The purpose of this study was to understand technology usage and preferences in cancer survivors with or at risk for AF, and to describe demographic factors ...
Wearable Devices for Vital Sign Monitoring in Hematology ...
Wearable devices offer continuous vital sign monitoring for hospitalized hematology and oncology patients, potentially enabling earlier detection of associated ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.